Gene · 1870
Papers2,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha. | Nat Commun | 2025 | 40846852 | PubTator, text mining | PubMed |
| USP18 promotes ferroptosis in lipopolysaccharide-induced human kidney organoids by stabilizing STING1. | Cell Biol Toxicol | 2025 | 40833519 | PubTator, text mining | PubMed |
| Core transcriptional regulatory circuit-regulated IGF2BP3 stabilizes E2F2 mRNA via m6A modification in neuroblastoma. | Carcinogenesis | 2025 | 40823720 | PubTator, text mining | PubMed |
| MicroRNA‑885‑5p regulates cell cycle progression in liver cancer cells. | Int J Mol Med | 2025 | 40808344 | PubTator, text mining | PubMed |
| Network analysis of master regulators associated with invasive phenotypes in multiple myeloma. | Front Cell Dev Biol | 2025 | 40741330 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. | MedComm (2020) | 2025 | 40740483 | PubTator, text mining | PubMed |
| YTHDC1 lactylation regulates its phase separation to enhance target mRNA stability and promote RCC progression. | Mol Cell | 2025 | 40680722 | PubTator, text mining | PubMed |
| Heat shock factor 1 promotes proliferation and chemoresistance in diffuse large B-cell lymphoma by enhancing the cell cycle and DNA repair. | Cell Death Dis | 2025 | 40675964 | PubTator, text mining | PubMed |
| TMPO-AS1-hsa-let-7b-5p-EZH2-RNA network predicts poor survival in basal-like breast cancer patients. | Rep Pract Oncol Radiother | 2025 | 40635988 | PubTator, text mining | PubMed |
| T-cell differentiation stage block bias confers hypermethylation and mediastinal preference in T-cell lymphoblastic lymphoma. | Clin Transl Med | 2025 | 40579780 | PubTator, text mining | PubMed |
| E2F2/MUC1 Enhances Cell Stemness of Hepatocellular Carcinoma by Regulating the Notch Signaling Pathway. | Dig Dis Sci | 2025 | 40531261 | PubTator, text mining | PubMed |
| Apigenin suppresses keratinocyte hyperproliferation and inflammation in psoriasis by inhibiting CDK2/E2F2 pathway. | Phytomedicine | 2025 | 40516287 | PubTator, text mining | PubMed |
| Transcriptional regulatory logic orchestrating lymphoid and myeloid cell fate decisions. | Front Immunol | 2025 | 40510370 | PubTator, text mining | PubMed |
| IFITM1 promotes proliferation, migration and macrophage-like transdifferentiation of vascular smooth muscle cells via c-Src/MAPK/GATA2/E2F2 pathway in atherosclerosis. | Biochem Pharmacol | 2025 | 40466954 | PubTator, text mining | PubMed |
| Multi-target RNA interference: A disruptive next-generation strategy for precision treatment of rheumatoid arthritis. | Int Immunopharmacol | 2025 | 40394795 | PubTator, text mining | PubMed |
| E2F2(E2F transcription factor 2) as a potential therapeutic target in meibomian gland carcinoma: evidence from functional and epigenetic studies. | BMC Cancer | 2025 | 40380087 | PubTator, text mining | PubMed |
| Recent insights into depression from transcriptomic analysis. | Postep Psychiatr Neurol | 2025 | 40376285 | PubTator, text mining | PubMed |
| BRD4 regulates m6A of ESPL1 mRNA via interaction with ALKBH5 to modulate breast cancer progression. | Acta Pharm Sin B | 2025 | 40370540 | PubTator, text mining | PubMed |
| Alterations in the humoral immunophenotype in sickle cell disease. | Br J Haematol | 2025 | 40368836 | PubTator, text mining | PubMed |
| scMINER: a mutual information-based framework for clustering and hidden driver inference from single-cell transcriptomics data. | Nat Commun | 2025 | 40341143 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1870/papers?page=4